Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - VidaMed, Inc. (NasdaqSC:VIDA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
46107 Landing Parkway
Fremont, CA 94538
Phone: (510) 492-4900
Fax: (510) 492-4999
Email: webmaster@vidamed.com
Employees (last reported count): 74
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 50%
·Over the last 6 months:
 · one insider sell; 5,000  shares
·Institutional: 30% (59% of float)
(57 institutions)
·Net Inst. Buying: 2.70M shares (+20.12%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
VidaMed, Inc. designs, develops and markets technologically and clinically advanced systems for urological conditions. Its focus is the treatment of the enlarged prostate known as benign prostatic hyperplasia (BPH). The Company's primary product, the patented Transurethral Needle Ablation (TUNA) system, is designed to offer a safe, cost-effective, minimally invasive treatment for BPH and an alternative to drug therapy and major surgery. The TUNA procedure is designed to restore and improve urinary flow and be performed in a physician's office or other outpatient setting. The TUNA system delivers low levels of radio frequency energy precisely into prostate tissue to relieve the symptoms associated with an enlarged prostate. The principal components of the TUNA system are the radio frequency generator, a reusable hand-piece and telescope and a single-use disposable catheter needed for each procedure.
More from Market Guide: Expanded Business Description

Financial Summary
VidaMed, Inc. designs, develops, manufactures and markets technologically and clinically advanced, cost effective systems for urological conditions, with an initial focus on the treatment of the enlarged prostate or benign prostatic hyperplasia. For the six months ended 6/30/01, revenues rose 6% to $5.2 million. Net loss rose 18% to $5.2 million. Results reflect an increase in procedure volume, offset by lower margins due to lower average prices.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Randy Lindholm, 45
Chairman, Pres, CEO
$1.0M
John Howe, 48
CFO, VP-Fin.
241K
Stephen Williams, 48
COO, VP-Operations
145K
Lewis Chapman, 50
VP of Global Marketing and Sales, CBO
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:VIDAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$2.00 
Recent Price$4.75 
52-Week High
on 29-May-2001
$7.95 
Beta0.55 
Daily Volume (3-month avg)235.3K
Daily Volume (10-day avg)127.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+94.8%
52-Week Change
relative to S&P500
+161.4%
Share-Related Items
Market Capitalization$170.7M
Shares Outstanding35.9M
Float18.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.30 
Earnings (ttm)-$0.35 
Earnings (mrq)-$0.07 
Sales (ttm)$0.26 
Cash (mrq)$0.27 
Valuation Ratios
Price/Book (mrq)16.06 
Price/EarningsN/A 
Price/Sales (ttm)18.43 
Income Statements
Sales (ttm)$8.55M
EBITDA (ttm)-$9.96M
Income available to common (ttm)-$11.5M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-70.44%
Return on Equity (ttm)-101.86%
Financial Strength
Current Ratio (mrq)2.79 
Debt/Equity (mrq)0.14 
Total Cash (mrq)$9.85M
Short Interest
As of 8-Aug-2001
Shares Short425.0K
Percent of Float2.4%
Shares Short
(Prior Month)
789.0K
Short Ratio2.25 
Daily Volume189.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.